Results 71 to 80 of about 717,050 (341)
Smoking reduction interventions for smoking cessation.
Cochrane Database of Systematic Reviews, 2018 BACKGROUND The standard way most people are advised to stop smoking is by quitting abruptly on a designated quit day. However, many people who smoke have tried to quit many times and may like to try an alternative method.
N. Lindson +4 more
semanticscholar +1 more source
American Journal of Industrial Medicine, EarlyView.ABSTRACT Public health registries collect and maintain demographic and health data on a cohort of people with a common disease or exposure. While disease registries have proliferated in recent decades, registries comprising persons with potentially hazardous exposures—known commonly as exposure registries—are rare.
Sammy Almashat +3 more
wiley +1 more source
Frontiers in Oral Health, 2023 Integration of smoking cessation program into routine oral health care has been advocated by World Health Organization since it brings extensive benefits to oral health. By tobacco cessation, patients are less prone to progression of periodontal disease,
H. L. Chan +3 more
doaj +1 more source
Occupational Asthma to UV‐Hardened Acrylate‐Based Car Paint
American Journal of Industrial Medicine, EarlyView.ABSTRACT Products containing acrylates are used in the coating of metal surfaces. Previous case series have reported occupational asthma caused by various acrylates including solitary cases related to coating products. We report on a case of occupational asthma caused by a new type of UV‐hardened car paint that included several reactive acrylates ...
Hille Suojalehto +4 more
wiley +1 more source
A ‘Cut-Down-To-Stop’ intervention for smokers who find it hard to quit: a qualitative evaluation
BMC Public Health, 2019 Background English Stop Smoking Services primarily deliver behavioural interventions to support abrupt quit attempts. Recent evidence suggests an alternative approach could be offered to clients involving a more gradual reduction of cigarettes smoked ...
J. Robinson +3 more
doaj +1 more source
Persisting Transglutaminase 6 Antibodies in Neurological Gluten‐Related Disorders
Annals of Neurology, EarlyView.Objective Gluten‐related autoimmunity can cause neurological disease, although the best way to diagnose and monitor such patients is unclear. Serological testing for antibodies against transglutaminase 6 (TG6) has been proposed; however, this is not widely available in clinical practice.
Iain D. Croall +6 more
wiley +1 more source
BMC Medical Genetics, 2018 Background The identification of variants in the nicotinic acetylcholine receptor (nAChR) subunit genes associated with smoking phenotypes are increasingly important for prevention and treatment of nicotine dependence.
Paulo Roberto Xavier Tomaz +8 more
doaj +1 more source
British medical journal, 2017 Objective To examine whether the increase in use of electronic cigarettes in the USA, which became noticeable around 2010 and increased dramatically by 2014, was associated with a change in overall smoking cessation rate at the population level.
Shu-Hong Zhu +4 more
semanticscholar +1 more source
Nicobrevin for smoking cessation [PDF]
Cochrane Database of Systematic Reviews, 2006 Nicobrevin is a proprietary product marketed as an aid to smoking cessation. It contains quinine, menthyl valerate, camphor and eucalyptus oil.The objective of this review was to assess the effects of Nicobrevin on long term smoking cessationWe searched the Cochrane Tobacco Addiction Group trials register.Randomized trials comparing Nicobrevin to ...
Stead, L, Lancaster, T
openaire +4 more sources
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Arthritis &Rheumatology, Accepted Article.Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source